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Background: The purpose of this study was to find the preoperative and intraoper-
ative factors that affect vein graft patency.
Methods: A total of 3715 graft angiograms in 1607 patients were studied for
recurrence of angina. The preoperative patient characteristics and intraoperative
variables were prospectively collected from patients who had primary coronary
artery bypass grafting during the period from 1977 to 1999. A total of 1339 (83%)
patients were male, with a mean age of 59 years. The mean period from operation
to reangiogram was 99 months. The saphenous vein was grafted to the left anterior
descending artery in 557 (15%), to the diagonal artery in 669 (18%), to the obtuse
marginal artery in 1300 (35%), to the right coronary artery in 409 (11%), and to the
posterior descending artery in 780 (21%) cases. Graft failure was defined as 80%
stenosis.
Results: During the course of the study, 2266 (61%) grafts were patent, and 1449
(39%) had failed. The patient variables that significantly reduced graft patency were
a younger age (P  .001) and an ejection fraction 30% (P  .047). Operative
variables associated with reduced graft patency were small coronary artery diameter
(P  .001), large conduit diameter (P  .001), and the coronary artery grafted
(lowest patency in the right coronary artery and maximum patency in the left
anterior descending artery territory; P .002). The interval from operation to repeat
angiogram (P  .001, with 78% patent at 1 year, 78% at 5 years, 60% at 10 years,
and 50% at 15 years) and the year in which the operation was performed (more
recent operations had better patency; P  .001) significantly affected graft patency.
Conclusions: Saphenous vein graft patency improved over the course of the study.
The best results were obtained in older patients with good left ventricular function.
Large-caliber arteries on the left system, when grafted with a small-diameter vein,
were associated with the best outcome.
Since the introduction of saphenous vein grafting in the late 1960s,1,2coronary artery bypass grafting, with or without arterial conduits,remains the treatment standard for management of intractable anginadue to coronary artery occlusive disease. However, it soon becameevident that the saphenous vein provided only palliation of the ongo-ing process, which is further complicated by vein graft atherosclero-
sis. Approximately 15% to 20% of vein grafts occlude in the first year, and half
occlude within the first 2 weeks. Thereafter, the annual occlusion rate is 1% to 2%
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from 1 and 6 years and 4% to 5% from 6 to 10 years. At 10
years, approximately 60% of vein grafts are patent; only
50% of these vein grafts remain free of significant steno-
sis.3-5 The pathology in the vein grafts documented by
angiography and histologic examinations includes acute
thrombosis and intimal hyperplasia during the first postop-
erative year and onset of progressive atherosclerosis beyond
3 to 5 years.3,4,6
Vein graft failure is one of the primary reasons for
coronary bypass reoperations. The economic impact is stag-
gering in an era of intense cost cutting. The fact that some
vein grafts remain free of disease for years whereas exten-
sive atherosclerosis develops in others remains an enigma.
The purpose of this study was to analyze 25 years of clinical
and angiographic data to delineate the patient and operative
variables responsible for vein graft failure and, thus, define
the patients most susceptible to recurrence of angina and
reoperations.
Method
Study Population
The study population included 1607 patients who had undergone a
primary coronary artery bypass surgery between 1977 and 1999
with at least 1 vein graft and who later had a recurrence of
symptoms that necessitated a coronary angiogram. Patients with a
concomitant procedure during the primary operation were ex-
cluded.
The preoperative patient characteristics and intraoperative vari-
ables were methodically recorded in the database since 1977. A
total of 3715 graft angiograms were studied in 1607 patients.
Because of missing data, a slightly reduced study population (3218
graft angiograms in 1402 patients) was used to analyze relevant
factors affecting graft patency.
The preoperative patient characteristics are described in Table
1. The data on cholesterol levels, incidence of smoking, and
peripheral vascular disease were largely missing. The number of
saphenous veins grafted to each of the target coronary arteries was
as follows: the left anterior descending artery (LAD), 557 (15%);
diagonal, 669 (18%); obtuse marginal artery, 1300 (35%); poste-
rior descending artery, 780 (21%); and right coronary artery
(RCA), 409 (11%).
The distribution of intervals from operation to angiogram is
described in Figure 1. The maximum number of angiograms was
performed between 90 months (7.5 years) and 110 months (9.2
years) after surgery. The mean interval from operation to reangio-
gram was 99 months, or 8.3 years. Aspirin was routinely given in
postoperative patients from 1983 and lipid-lowering agents were
routinely given from 1994.
Operation
Coronary artery bypass grafting was performed by a similar pro-
tocol by all surgeons. The left internal thoracic artery was used
from 1982. All operations were performed on cardiopulmonary
bypass with the use of antegrade blood cardioplegia in the early
part of the study and with antegrade/retrograde blood cardioplegia
in the later part.
The distal anastomosis to the target coronary artery was con-
structed end to side or side to side. Proximal anastomosis was
almost always to the aorta. In the latter part of the study, especially
after 1995, we commenced extensive arterial revascularization. A
total of 1456 internal thoracic and 226 radial arterial conduits were
used in this group of 1607 patients.
Veins were harvested by a conventional open “no touch” tech-
nique. Veins from the calf were generally preferred. Veins were
dilated to their naturally distended state, and overdistention was
avoided. In the earlier part of the study, veins were dilated and
stored in Ringer’s lactate, but from 1983, a solution containing
Ringer’s lactate, blood, papaverine (1 mmol/L), and heparin (5000
U/100 mL) was used.
Angiographic Analysis
The native and graft angiograms were performed in a standard
fashion. The left internal thoracic artery and each aortic anasto-
mosis were selectively injected. If the status of vein grafts could
not be determined by graft or stump injection, an aortic root
angiogram was performed. In patients who had 2 or more postop-
erative angiograms, the first angiogram was used for analytical
purposes. Two cardiologists and a surgeon read the angiograms.
The method of reporting was uniform. All the grafts were de-
scribed in detail, including the degree of stenosis and coronary
grafting.
A graft was considered patent when it had less than 80%
stenosis, and the entire course of the graft was visualized, includ-
ing proximal anastomosis, distal anastomosis, and opacification of
the distal target coronary artery. A graft was considered to have
failed if it had 80% stenosis or more or was completely occluded.
In sequential vein grafts, each segment was analyzed as a separate
graft.
Statistical Analysis
In the following analysis, a data set was created with key variables
that had no missing data. This resulted in a data set of 3218 grafts
from 1402 patients. The time of graft failure was usually not
recognizable and could have occurred any time between the oper-
ation and angiogram. Standard time-related analysis overestimates
graft patency. We have therefore analyzed graft patency by using
categorical time intervals.
A generalized linear mixed model was fitted to the binary
variable, defined as 1 if graft stenosis or occlusion was 80% or
more and 0 otherwise. This is an extension of logistic regression
that allows for 2 levels of variation that are present in the data.
TABLE 1. Baseline patient characteristics
Variable Data
Mean age (y) 59
Sex (male) 1339 (83%)
NYHA class III or IV 325 (20%)
Diabetes 161 (10%)
Hypertension 932 (58%)
LVEF 30% 55 (3.4%)
Urgent operation 158 (9.8%)
NYHA, New York Heart Association; LVEF, left ventricular ejection fraction.
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Some variables are constant for all grafts from a given patient: for
example, age, sex, year of operation, and interval to angiogram.
Other variables pertain to individual grafts and therefore take
different values for grafts from the same patient, for example, the
coronary artery to which the graft is anastomosed. Unlike standard
logistic regression, the analysis allows for incorporation of these 2
levels of variation.7 The model is multivariate in the usual sense
that each variable’s effect is adjusted for the effects of other
variables considered. The model was fitted by using S-Plus (In-
sightful Corporation, Seattle, Wash) and the MASS library of
additional functions.8
Results
A total of 2267 (61%) grafts were patent: 1858 (50%) grafts
had 0% to 19% stenosis, 106 (2.85%) grafts had 20% to
40% stenosis, 121 (3.25%) grafts had 40% to 60% stenosis,
and 182 (4.9%) grafts had 60% to 79% stenosis. A total of
1449 (39%) grafts failed: 334 (9%) grafts had 80% to 99%
stenosis, whereas 1115 (30%) grafts were completely oc-
cluded. The factors associated with graft patency were an-
alyzed as patient and operative variables; the detailed results
are shown in Table 2. With graft failure as the outcome,
odds ratios, 95% confidence intervals, and P values are
shown for the patient and operative variables. Some vari-
ables were included in the model as continuous, and others
were categorical or binary. The odds ratio for a continuous
variable corresponds to a difference of a specified number
of units. For example, the estimated odds ratio of graft
failure for an interval between operation and angiogram of
15 years, compared with 5 years or any other interval of 10
years, was 1.68 (95% confidence interval, 1.28 to 2.21). For
categorical and binary variables, 1 level was chosen as a
baseline, and odds ratios for the other levels were expressed
in relation to it. For example, the odds ratio of graft failure
for the target artery being diagonal, compared with LAD,
was 1.29 (95% confidence interval, 0.99 to 1.68). Finally,
the P values shown are tests of significance for each vari-
able separately; in the case of a categorical variable at
several levels, the single P value tests the null hypothesis
that the risk of graft failure was the same for all levels.
The following list describes the relationship of patient
variables to graft patency:
● Younger age (P  .001) and left ventricular ejection
fraction 30% (P  .047) significantly reduced graft
patency. Male sex (P  .9), diabetes (P  .5), hyper-
tension (P  .5), and urgent operation (P  .9) were
not significantly associated with graft patency (Table
2).
● Year of operation (P  .001) significantly affected
graft patency. For any given angiogram interval, more
recently performed operations were associated with
better graft patency.
● Interval from operation to angiogram (Figure 2) sig-
nificantly affected graft patency (P  .001): 79 grafts
were studied at less than 1 year, 670 grafts between 1
and 4 years, 1603 grafts between 5 and 9 years, 1084
grafts at 10 to 14 years, and 279 grafts at 15 years.
Graft patency of angiograms studied at less than 1 year,
1 to 4 years, 5 to 9 years, 10 to 14 years, and15 years
was 78%, 78%, 60%, 50%, and 50%, respectively.
Operative variables were related to graft patency as fol-
lows:
● The target coronary artery grafted (P  .002) signifi-
cantly affected graft patency. Grafts to the RCA had
the worst patency, and those to the LAD had the best
Figure 1. Number of angiograms performed in relation to the time interval after the operation.
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patency. The order of increasing patency was RCA3
obtuse marginal artery 3 posterior descending artery
3 diagonal 3 LAD (Table 2).
● Target coronary artery diameter (P  .001) signifi-
cantly affected graft patency. The worst to best graft
patency was endarterectomy3 0 to 0.9 mm3 1.0 to 1.4
mm3 1.5 to 1.9 mm3 2 to 2.4 mm3 2.5 to 3.4 mm.
● Conduit diameter (P  .001) significantly affected
graft patency. Large-diameter veins were associated
with worst graft patency; better graft patency was
associated with smaller conduit size. The worst to best
graft patency was5.5 mm3 4.5 to 5.4 mm3 3.5 to
4.4 mm 3 2.5 to 3.4 mm 3 2 to 2.4 mm.
● Conduit wall thickness (P  .07) showed a trend
toward affecting graft patency. The conduit wall thick-
ness was graded as thick, normal, and thin veins. Thick
wall was defined as 1.5 mm, normal as 1.0 to 1.5
mm, and thin as 1.0 mm. Only 7 conduits were
described as thin. Thick-walled veins were associated
with worst graft patency.
● Target coronary artery stenosis (P  .18) and distal
anastomosis type, that is, end to side or side to side
(sequential), were not significantly associated with
graft patency (P  .9).
Discussion
This is one of the largest reported angiographic studies4 of
saphenous vein graft patency. The study was performed
over 25 years and analyzed clinical and operative variables.
The results confirm that 20% of the grafts occlude within
the first year of surgery. After the first year, the annual
occlusion rate is 2% to 5%. At 10 to 14 years, 50% of the
grafts were patent, 30% were completely occluded, and
20% showed varying degrees of atherosclerotic changes.
This proportion was similar at 15 years and beyond.
Thrombosis and neointimal hyperplasia are considered to
be the cause of occlusion in the first year, and subsequently
atherosclerosis begins after 3 years.3,4,6 The cause of early
occlusion is probably related to the surgical technique of
harvesting and storing the saphenous vein and the precision
TABLE 2. Results of a multivariate model: odds ratios (OR) and 95% confidence intervals (CI) for the associations between
patient and operative variables and graft occlusion
Variable Baseline Comparison OR 95% CI P value
Patient variables
Year of operation x x  10 0.37 0.27-0.51 .001
Age (y) x x  10 0.76 0.68-0.86 .001
Interval between operation and angiogram (y) x x  10 1.68 1.28-2.21 .001
Sex Female Male 1.02 0.78-1.34 .9
Hypertension No Yes 1.07 0.88-1.31 .5
Diabetes No Yes 1.12 0.81-1.55 .5
Low ejection fraction (30%) No Yes 0.59 0.36-0.99 .047
Urgent operation No Yes 0.99 0.71-1.39 .9
NYHA class III or IV No Yes 0.96 0.69-1.32 .8
Operative variables
Target artery LAD Diagonal 1.29 0.99-1.68 .002
Marginal 1.39 1.11-1.75
Right 1.63 1.22-2.17
PDA or LV
Br
1.34 1.03-1.74
Target artery diameter (mm) 0-0.9 1.0-1.4 1.59 0.44-5.79 .001
1.5-1.9 0.93 0.26-3.35
2.0-2.4 0.78 0.22-2.82
2.5-3.4 0.61 0.16-2.30
Endarterectomy 1.69 0.27-10.50
Target artery stenosis 1%-39% 40%-59% 1.53 0.66-3.54 .18
60%-79% 1.18 0.52-2.65
80%-99% 1.08 0.48-2.42
Total 1.28 0.57-2.88
Conduit diameter (mm) 1.5-2.4 2.5-3.4 1.09 0.43-2.77 .001
3.5-4.4 1.62 0.64-4.11
4.5-5.4 2.17 0.83-5.67
5.5 2.36 0.77-7.16
Conduit wall thickness Thin Normal 1.29 1.04-1.59 .07
Thick 8.04 1.20-53.78
Distal anastomosis End to side Side to side 1.01 0.63-1.62 .9
PDA, Posterior descending artery; NYHA, New York Heart Association; LV Br, left ventricular branch.
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of anastomosis.6,9 The precise cause of late atherosclerosis
remains unknown, although many theories exist and may
provide avenues for improvement in vein graft patency.6
Recently, to overcome these shortcomings, arterial conduits
are used with increasing frequency. The internal thoracic
artery does not usually develop late postoperative athero-
sclerosis, and its patency at 10 years is approximately
90%.10 However, because of the relative ease with which
veins can be harvested and anastomosed, the saphenous vein
remains widely used, and improvement in their long-term
patency remains a major objective.
In our study, more recent operations were associated
with better graft patency. This could be due to routine use of
aspirin, vigorous treatment with cholesterol-lowering
agents, and better harvesting, preparation, and storing tech-
niques of vein grafts that have evolved over the last 3
decades. Aspirin (325 mg/d) is associated with improved
saphenous vein graft patency during the first year.11 The
post–coronary bypass graft trial12 showed that aggressive
decreasing of low-density lipoprotein cholesterol to 100
mg/dL decreased obstructive changes in saphenous vein
grafts by 31%. Harvesting, preparation, and storing tech-
niques significantly affect graft patency.6,9,13
Younger age and a lower ejection fraction independently
reduced vein graft patency, unlike in other studies.13,14 A
possible explanation is that younger patients have higher
prevalence of risk factors (variables such as smoking and
cholesterol, which were not analyzed in our study) and more
severe coronary disease. Reduced ejection fraction may
indicate large areas of infarcted myocardium with poor
distal runoff. In our study, variables such as hypertension,
sex, diabetes, and myocardial infarction did not affect graft
patency, similar to other reports.13,14
Severity of coronary artery stenosis15 and type of distal
anastomosis13,16 did not affect graft patency in our study,
unlike other reports. In this study, 91% of the veins were
grafted to vessels with 60% stenosis. There was no sig-
nificant difference in the graft patency when the target
artery was totally occluded or had a stenosis of 60% to 79%
or 80% to 99%. Veins, unlike arterial grafts, are less sus-
ceptible to spasm and are less affected by competitive flow
and autoregulation. Target arteries with 70% stenosis are
grafted. A significant association was found between target
coronary artery diameter and graft patency, similar to other
reports.13,17 The most likely reason is that a large-diameter
vessel has a better runoff and, therefore, better graft pa-
tency.
The saphenous vein conduit diameter and wall thickness
significantly affected graft patency, similar to the results of
earlier series.13,17 Poor results that followed the use of
large-diameter and thick-walled saphenous veins may be the
result of low-velocity flow within the conduit leading to
deposition of oxidized low-density lipoprotein in the graft
wall. The thigh vein is often harvested because of convenience
and the mistaken belief that bigger is better. Indeed, the saphe-
nous vein is often harvested by the endoscopic technique or
with the aid of a vein stripper, which are better suited to
above-knee use. This study conclusively identifies that larger
and thicker-walled veins that are typically harvested from the
thigh are associated with poor long-term patency.
In this study, a novel statistical analysis was used. Be-
cause some variables are unique to an individual patient and
are constant for all grafts for that patient, whereas other
variables are unique to a graft and vary with the patient, it
is invalid to use ordinary logistic regression. To put it
another way, to do so would be to treat the data set of 3218
Figure 2. Graft patency at <1 year, 1 to 4 years, 5 to 9 years, and 10 to 14 years after the primary operation.
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grafts as if it came from 3218 patients, each with a single
graft, when in fact there were 1402 patients with 3218
grafts. This data set violates the assumption of indepen-
dence between observations that is required for the use of
ordinary logistic regression. The graft stenosis outcomes for
grafts from the same individual are not independent from
one another. The method used is a newly available approach
that accounts properly for the 2 levels of variation and
allows valid inferences to be drawn.7
Our current practice is to use arterial grafts. However,
when required, veins are harvested from the calf because
they are a better size match to the coronary arteries. Veins
of normal wall thickness are preferred. The saphenous vein
is suitable for grafting vessels with intermediate to severe
stenosis. The best results are obtained when veins are
grafted to the left system.
Our study had several limitations. The graft failure event
was assumed to have occurred at the time of the angiogram,
but the graft could have actually blocked at any time from
the date of the operation to the date of the angiogram. Our
patient population included those who had symptom-di-
rected angiography, and this is only a small proportion
(15%) of all patients who underwent surgery during that
time. Some of the patient variables known to affect graft
patency were not analyzed because of missing data. The
measurements for operative variables are based on visual
assessment and may vary from surgeon to surgeon. Finally,
different calendar periods may be associated with use of
different methods of harvesting, preparation, and anasto-
motic techniques.
Conclusion
Saphenous vein graft patency improved with time. The best
results were obtained in older patients with good left ven-
tricular function. Large-caliber arteries on the left system,
when grafted with a small-diameter vein, were associated
with the best outcome.
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